14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 133 days ( -71.04 % )
Last Price $15.00 0 %
High/ Low $15.00 - $15.00 0%
Chg 7 Days N/A $15.00 $15.00
Chg 30 Days N/A $15.00 $15.00
Chg 12 mos 170.76 % $5.54 $15.00
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 217.09 % Width: 30.44 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $49.52 - $64.59 230.10 % - 330.60 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Jan 11, 2023 - 67 days
Long MA avg 12 mos Buy Jun 16, 2022 - 210 days
Short/Long MA avg 12 mos Buy Jun 23, 2022 - 206 days
Pivot Short Sell Apr 17, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About AVEO Pharmaceuticals

AVEO Pharmaceuticals AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the treatment of RCC, HCC, immunologically cold tumors, and CCA. The company has also completed a Phase II ... AVEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT